Sites are facing a bottleneck in trial operations as they juggle restarting nonCOVID-19 trials, continuing ongoing COVID-19 trials and returning to their prepandemic plans for new trials. Read More
This monthly feature presents a variety of questions from clinical trial professionals with answers from WCG ‘s expert staff. This month features Christopher Doyle, director of IBC Services, Daniel Kavanagh, senior scientific adviser, gene therapy, and Yvonne Higgins, WCG IRB quality assurance adviser. Read More
A new poll of clinical research professionals suggests remote monitoring, a tactic necessitated by the pandemic, will become more commonplace once the global health crisis ends. Read More